Cargando…

Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway

BACKGROUND: Diabetic nephropathy serves as one of the most regular microvascular complications of diabetes mellitus and is the main factor that causes end-stage renal disease and incident mortality. As the beneficial effect and minute adverse influence of Celastrol on the renal system requires furth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Yusong, Fu, Chengxiao, Zhang, Huimin, Zhang, Min, Xie, Hui, Tong, Xiaopei, Li, Yao, Hou, Zhenyan, Fan, Xinrong, Yan, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583204/ https://www.ncbi.nlm.nih.gov/pubmed/33097050 http://dx.doi.org/10.1186/s12906-020-03050-y

Ejemplares similares

Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway
por: Zhu, Biqiang, et al.
Publicado: (2019)

Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments
por: Wang, Shuhui, et al.
Publicado: (2022)

Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway
por: Chen, Pingping, et al.
Publicado: (2022)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)

Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
por: Zhu, Yingjun, et al.
Publicado: (2020)

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
por: Tong, Chenhao, et al.
Publicado: (2021)

Insulin upregulates betatrophin expression via PI3K/Akt pathway
por: Lu, Puhan, et al.
Publicado: (2017)

LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway
por: Xu, Debin, et al.
Publicado: (2022)

PERK in POMC neurons connects celastrol with metabolism
por: He, Zhenyan, et al.
Publicado: (2021)

Silencing of SPP1 Suppresses Progression of Tongue Cancer by Mediating the PI3K/Akt Signaling Pathway
por: Zhang, Qiaoli, et al.
Publicado: (2020)

Targeting PI3K/Akt signal transduction for cancer therapy
por: He, Yan, et al.
Publicado: (2021)

Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
por: Xiao-pei, Huang, et al.
Publicado: (2018)

SYST-16 ANXA5 PROMOTES GLIOMA PROGRESSION THROUGH THE FAK/PI3K/AKT PATHWAY
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway
por: Ou, Yi, et al.
Publicado: (2021)

Therapeutic approaches to slowing the progression of diabetic nephropathy – is less best?
por: Vivian, Eva, et al.
Publicado: (2013)

Dendrobium mixture attenuates renal damage in rats with diabetic nephropathy by inhibiting the PI3K/Akt/mTOR pathway
por: Chen, Yong, et al.
Publicado: (2021)

Epimedium sagittatum Maxim ameliorates adriamycin‐induced nephropathy by restraining inflammation and apoptosis via the PI3K/AKT signaling pathway
por: Wang, Ru, et al.
Publicado: (2023)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
por: Lisi, Lucia
Publicado: (2020)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

L-Borneol 7-O-[β-D-Apiofuranosyl-(1→6)]-β-D-Glucopyranoside Alleviates Myocardial Ischemia-Reperfusion Injury in Rats and Hypoxic/Reoxygenated Injured Myocardial Cells via Regulating the PI3K/AKT/mTOR Signaling Pathway
por: Tong, Ziyi, et al.
Publicado: (2022)

MDA-19 Suppresses Progression of Melanoma Via Inhibiting the PI3K/Akt Pathway
por: Dang, Ningning, et al.
Publicado: (2018)

Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways
por: Zhao, Tingting, et al.
Publicado: (2023)

Silencing of TRB3 Ameliorates Diabetic Tubule Interstitial Nephropathy via PI3K/AKT Signaling in Rats
por: Ma, Yali, et al.
Publicado: (2017)

Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats
por: Li, Shaohua, et al.
Publicado: (2022)

Astilbin-induced inhibition of the PI3K/AKT signaling pathway decelerates the progression of osteoarthritis
por: Chen, Chunlin, et al.
Publicado: (2020)

Formulation and Evaluation of Celastrol-Loaded Liposomes
por: Song, Jie, et al.
Publicado: (2011)

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
por: Duan, Shiyu, et al.
Publicado: (2018)

Correction: Systematic identification of celastrol-binding proteins reveals that Shoc2 is inhibited by celastrol
Publicado: (2021)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
por: Deng, Shuo, et al.
Publicado: (2022)

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
por: Cui, Yong, et al.
Publicado: (2022)

Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
por: Liu, Yanhui, et al.
Publicado: (2023)

Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway
por: Miao, Lifeng, et al.
Publicado: (2019)

RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer
por: Shi, Dazun, et al.
Publicado: (2022)

Induction of the ER stress response in NRVMs is linked to cardiotoxicity caused by celastrol: Celastrol cardiotoxicity involves the ER stress response
por: Chen, Zhong, et al.
Publicado: (2022)

ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
por: Liu, Gao, et al.
Publicado: (2021)

Autophagy in the pharmacological activities of celastrol (Review)
por: Zhang, Caixia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lj0cmvv0e4v3vb7sfivocpo20u